Embed this press release by copying the code below:
CEL-SCI Corporation Holds Clinical Investigator Meeting for 56 European Centers Participating in Ongoing Phase III Cancer Trial with Multikine
CEL-SCI Corporation Holds Clinical Investigator Meeting for 56 European Centers Participating in Ongoing Phase III Cancer Trial with Multikine